Insulin Pumps, Including Sensor-Augmented, Enter Competitive Bidding

Now that insulin pumps are part of CMS’ competitive bidding program, there is a possibility of reimbursement reductions down the road. And in a separate process, CMS denied Medtronic’s request to establish a new HCPCS code for sensor-augmented insulin pumps.

More from Policy & Regulation

More from Medtech Insight